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Background
Double sensitization to both honeybee (Apis mellifera)
and Yellow Jacket (Vespula ssp.) venom is common in
up to 59% of Northern European Hymenoptera venom
allergic patients and this rate is more than 50% in the
United States. In Brazil yellow jacket is not a common
wasp, but Polistes sp. and Polybia paulista poses the
major risk for Brazilian patients. Reports about double
sensitization involving honey bee and fire ant (Solenopsis
invicta) are rare and there is nothing described about
multi-sensitization to insects. Cross-reacting carbohy-
drate determinants (CCDs) are not present in Polistessp.
venom and are not yet described for Polybia paulista
neither Solenopsis invicta. Component-resolved analysis
with recombinant species-specific major allergens may
help to distinguish true double sensitization from cross-
reactivity, except for Polybia paulistaallergens for which
these commercial tests are not yet available. Although
there is no international consensus on whether immu-
notherapy regimens should generally include all venoms
in multi-sensitized patients the recommendation is that
immunotherapy (IT) should be extended to all venoms
for which test results are positive and patients might
potentially react to.
Methods
We selected a group of ten patients with clinical manifesta-
tions of anaphylaxis presenting symptoms that included
urticaria, angioedema, diarrhea, respiratory symptoms and
loss of consciousness that are sensitized to honeybee,
wasps (Polistes and Polybia) and fire ant. They were tested
by ImmunoCap, Skin prick test (SPT), Dot Blot and
Western Blotting (WB) with Apis mellifera, Polistes sp. and
Solenopsis invicta extracts commercially available and also
Polybia paulista venom extract produced in our laboratory.
Results
Patients are positive to four venoms tested in Dot blot,
WB and SPT. Five patients presented ImmunoCAP <0.35
for one or two venoms tested. WB revealed that patients
are recognizing different bands in gel when comparing dif-
ferent venoms suggesting there is no cross-reactivity.
Some bands recognized by specific IgEs would be new
allergens, since they present distinct molecular weights
from allergens already described. Cross-reactivity due to
CCD recognition remains to be confirmed.
Conclusions
This is the first report of multisensitization to honeybee,
Solenopsis, Polybia and Polistes and considering clinical
history, SPT and laboratory results patients presented here
should be submitted to IT to all venoms tested. It is
important to remark that Polybiapaulista venom is not
commercially available for treatment and IT to Solenopsis
is still not well established. Next steps are to check the
presence of CCD in Solenopsis and Polybia venoms and
also to identify new IgE reacting molecules.
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